http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 26 Aug 2026 06:02:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++PSYENCE+BIOMEDICAL+LTD.++++++++++++++/26976725.html si-local-file:///var/storage/secattach/20260826/26976725.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++PSYENCE+BIOMEDICAL+LTD.++++++++++++++/26976725.html Wed, 26 Aug 2026 06:02:00 -0400 O.03270327 O.65258044 PBM PSYGD http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++PSYENCE+BIOMEDICAL+LTD.++++++++++++++/26976725.html si-local-file:///var/storage/secattach/20260826/26976725.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++PSYENCE+BIOMEDICAL+LTD.++++++++++++++/26976725.html Wed, 26 Aug 2026 06:02:00 -0400 O.03270327 O.65258044 PBM PSYGD http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++PSYENCE+BIOMEDICAL+LTD.++++++++++++++/26976725.html si-local-file:///var/storage/secattach/20260826/26976725.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++PSYENCE+BIOMEDICAL+LTD.++++++++++++++/26976725.html Wed, 26 Aug 2026 06:02:00 -0400 O.03270327 O.65258044 PBM PSYGD http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++PSYENCE+BIOMEDICAL+LTD.++++++++++++++/26976725.html si-local-file:///var/storage/secattach/20260826/26976725.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++PSYENCE+BIOMEDICAL+LTD.++++++++++++++/26976725.html Wed, 26 Aug 2026 06:02:00 -0400 O.03270327 O.65258044 PBM PSYGD http://www.streetinsider.com/SEC+Filings/Form++F-3++++++++PSYENCE+BIOMEDICAL+LTD.++++++++++++++/26976726.html si-local-file:///var/storage/secattach/20260826/26976726.html http://www.streetinsider.com/SEC+Filings/Form++F-3++++++++PSYENCE+BIOMEDICAL+LTD.++++++++++++++/26976726.html Wed, 26 Aug 2026 06:02:00 -0400 O.03270327 O.65258044 PBM PSYGD http://www.streetinsider.com/SEC+Filings/Form++F-3++++++++PSYENCE+BIOMEDICAL+LTD.++++++++++++++/26976726.html si-local-file:///var/storage/secattach/20260826/26976726.html http://www.streetinsider.com/SEC+Filings/Form++F-3++++++++PSYENCE+BIOMEDICAL+LTD.++++++++++++++/26976726.html Wed, 26 Aug 2026 06:02:00 -0400 O.03270327 O.65258044 PBM PSYGD http://www.streetinsider.com/SEC+Filings/Form++F-3++++++++PSYENCE+BIOMEDICAL+LTD.++++++++++++++/26976726.html si-local-file:///var/storage/secattach/20260826/26976726.html http://www.streetinsider.com/SEC+Filings/Form++F-3++++++++PSYENCE+BIOMEDICAL+LTD.++++++++++++++/26976726.html Wed, 26 Aug 2026 06:02:00 -0400 O.03270327 O.65258044 PBM PSYGD http://www.streetinsider.com/SEC+Filings/Form++F-3++++++++PSYENCE+BIOMEDICAL+LTD.++++++++++++++/26976726.html si-local-file:///var/storage/secattach/20260826/26976726.html http://www.streetinsider.com/SEC+Filings/Form++F-3++++++++PSYENCE+BIOMEDICAL+LTD.++++++++++++++/26976726.html Wed, 26 Aug 2026 06:02:00 -0400 O.03270327 O.65258044 PBM PSYGD http://www.streetinsider.com/Corporate+News/Trump+highlights+ibogaine+development+push%2C+Psyence+BioMed+responds/26945534.html <p>President Donald Trump announced that the University of Miami has provided the U.S. federal government with its original 1994 ibogaine Investigational New Drug application, which he said could help accelerate ibogaine's development as a medical treatment in the United States.</p><p>Trump also highlighted progress since his April executive order, including Department of Health and Human Services research funding, an HHS-VA collaboration, FDA guidance, and efforts to expand Right to Try access for veterans. He concluded with a call for additional companies and institutions to participate in ibogaine development efforts.</p><p>Psyence BioMed Ltd. (Nasdaq: PBM), a biopharmaceutical company focused on nature-derived psychedelic compounds, http://www.streetinsider.com/Corporate+News/Trump+highlights+ibogaine+development+push%2C+Psyence+BioMed+responds/26945534.html Tue, 18 Aug 2026 17:25:35 -0400 PBM PSYGD http://www.streetinsider.com/Corporate+News/Trump+highlights+ibogaine+development+push%2C+Psyence+BioMed+responds/26945534.html <p>President Donald Trump announced that the University of Miami has provided the U.S. federal government with its original 1994 ibogaine Investigational New Drug application, which he said could help accelerate ibogaine's development as a medical treatment in the United States.</p><p>Trump also highlighted progress since his April executive order, including Department of Health and Human Services research funding, an HHS-VA collaboration, FDA guidance, and efforts to expand Right to Try access for veterans. He concluded with a call for additional companies and institutions to participate in ibogaine development efforts.</p><p>Psyence BioMed Ltd. (Nasdaq: PBM), a biopharmaceutical company focused on nature-derived psychedelic compounds, http://www.streetinsider.com/Corporate+News/Trump+highlights+ibogaine+development+push%2C+Psyence+BioMed+responds/26945534.html Tue, 18 Aug 2026 17:25:35 -0400 PBM PSYGD http://www.streetinsider.com/Press+Releases/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html <p>NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company focused on the development and supply of nature-derived psychedelic compounds for clinical research and therapeutic applications, today welcomed President Donald J. Trump’s latest announcement supporting the accelerated development of ibogaine as a potential medical treatment in the United States.</p> <p>President Trump announced today that the University of Miami has provided the U.S. Federal Government with its original 1994 ibogaine Investigational New Drug (“IND”) application, which he said could help accelerate ibogaine’s development as a medical treatment http://www.streetinsider.com/Press+Releases/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html Tue, 18 Aug 2026 17:23:00 -0400 A.13296698 O.03270327 O.03955888 O.65258044 PBM PSYGD http://www.streetinsider.com/Press+Releases/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html <p>NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company focused on the development and supply of nature-derived psychedelic compounds for clinical research and therapeutic applications, today welcomed President Donald J. Trump’s latest announcement supporting the accelerated development of ibogaine as a potential medical treatment in the United States.</p> <p>President Trump announced today that the University of Miami has provided the U.S. Federal Government with its original 1994 ibogaine Investigational New Drug (“IND”) application, which he said could help accelerate ibogaine’s development as a medical treatment http://www.streetinsider.com/Press+Releases/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html Tue, 18 Aug 2026 17:23:00 -0400 A.13296698 O.03270327 O.03955888 O.65258044 PBM PSYGD http://www.streetinsider.com/Press+Releases/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html <p>NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company focused on the development and supply of nature-derived psychedelic compounds for clinical research and therapeutic applications, today welcomed President Donald J. Trump’s latest announcement supporting the accelerated development of ibogaine as a potential medical treatment in the United States.</p> <p>President Trump announced today that the University of Miami has provided the U.S. Federal Government with its original 1994 ibogaine Investigational New Drug (“IND”) application, which he said could help accelerate ibogaine’s development as a medical treatment http://www.streetinsider.com/Press+Releases/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html Tue, 18 Aug 2026 17:23:00 -0400 A.13296698 O.03270327 O.03955888 O.65258044 PBM PSYGD http://www.streetinsider.com/Press+Releases/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html <p>NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company focused on the development and supply of nature-derived psychedelic compounds for clinical research and therapeutic applications, today welcomed President Donald J. Trump’s latest announcement supporting the accelerated development of ibogaine as a potential medical treatment in the United States.</p> <p>President Trump announced today that the University of Miami has provided the U.S. Federal Government with its original 1994 ibogaine Investigational New Drug (“IND”) application, which he said could help accelerate ibogaine’s development as a medical treatment http://www.streetinsider.com/Press+Releases/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html Tue, 18 Aug 2026 17:23:00 -0400 A.13296698 O.03270327 O.03955888 O.65258044 PBM PSYGD http://www.streetinsider.com/Press+Releases/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html <p>NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company focused on the development and supply of nature-derived psychedelic compounds for clinical research and therapeutic applications, today welcomed President Donald J. Trump’s latest announcement supporting the accelerated development of ibogaine as a potential medical treatment in the United States.</p> <p>President Trump announced today that the University of Miami has provided the U.S. Federal Government with its original 1994 ibogaine Investigational New Drug (“IND”) application, which he said could help accelerate ibogaine’s development as a medical treatment http://www.streetinsider.com/Press+Releases/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html Tue, 18 Aug 2026 17:23:00 -0400 A.13296698 O.03270327 O.03955888 O.65258044 PBM PSYGD http://www.streetinsider.com/Press+Releases/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html <p>NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company focused on the development and supply of nature-derived psychedelic compounds for clinical research and therapeutic applications, today welcomed President Donald J. Trump’s latest announcement supporting the accelerated development of ibogaine as a potential medical treatment in the United States.</p> <p>President Trump announced today that the University of Miami has provided the U.S. Federal Government with its original 1994 ibogaine Investigational New Drug (“IND”) application, which he said could help accelerate ibogaine’s development as a medical treatment http://www.streetinsider.com/Press+Releases/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html Tue, 18 Aug 2026 17:23:00 -0400 A.13296698 O.03270327 O.03955888 O.65258044 PBM PSYGD http://www.streetinsider.com/Globe+Newswire/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html <p>NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company focused on the development and supply of nature-derived psychedelic compounds for clinical research and therapeutic applications, today welcomed President Donald J. Trump’s latest announcement supporting the accelerated development of ibogaine as a potential medical treatment in the United States.</p> <p>President Trump announced today that the University of Miami has provided the U.S. Federal Government with its original 1994 ibogaine Investigational New Drug (“IND”) application, which he said could help accelerate ibogaine’s development as a medical treatment http://www.streetinsider.com/Globe+Newswire/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html Tue, 18 Aug 2026 17:23:00 -0400 A.13296698 O.03270327 O.03955888 O.65258044 PBM PSYGD http://www.streetinsider.com/Globe+Newswire/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html <p>NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company focused on the development and supply of nature-derived psychedelic compounds for clinical research and therapeutic applications, today welcomed President Donald J. Trump’s latest announcement supporting the accelerated development of ibogaine as a potential medical treatment in the United States.</p> <p>President Trump announced today that the University of Miami has provided the U.S. Federal Government with its original 1994 ibogaine Investigational New Drug (“IND”) application, which he said could help accelerate ibogaine’s development as a medical treatment http://www.streetinsider.com/Globe+Newswire/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html Tue, 18 Aug 2026 17:23:00 -0400 A.13296698 O.03270327 O.03955888 O.65258044 PBM PSYGD http://www.streetinsider.com/Globe+Newswire/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html <p>NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company focused on the development and supply of nature-derived psychedelic compounds for clinical research and therapeutic applications, today welcomed President Donald J. Trump’s latest announcement supporting the accelerated development of ibogaine as a potential medical treatment in the United States.</p> <p>President Trump announced today that the University of Miami has provided the U.S. Federal Government with its original 1994 ibogaine Investigational New Drug (“IND”) application, which he said could help accelerate ibogaine’s development as a medical treatment http://www.streetinsider.com/Globe+Newswire/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html Tue, 18 Aug 2026 17:23:00 -0400 A.13296698 O.03270327 O.03955888 O.65258044 PBM PSYGD http://www.streetinsider.com/Globe+Newswire/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html <p>NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company focused on the development and supply of nature-derived psychedelic compounds for clinical research and therapeutic applications, today welcomed President Donald J. Trump’s latest announcement supporting the accelerated development of ibogaine as a potential medical treatment in the United States.</p> <p>President Trump announced today that the University of Miami has provided the U.S. Federal Government with its original 1994 ibogaine Investigational New Drug (“IND”) application, which he said could help accelerate ibogaine’s development as a medical treatment http://www.streetinsider.com/Globe+Newswire/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html Tue, 18 Aug 2026 17:23:00 -0400 A.13296698 O.03270327 O.03955888 O.65258044 PBM PSYGD http://www.streetinsider.com/Globe+Newswire/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html <p>NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company focused on the development and supply of nature-derived psychedelic compounds for clinical research and therapeutic applications, today welcomed President Donald J. Trump’s latest announcement supporting the accelerated development of ibogaine as a potential medical treatment in the United States.</p> <p>President Trump announced today that the University of Miami has provided the U.S. Federal Government with its original 1994 ibogaine Investigational New Drug (“IND”) application, which he said could help accelerate ibogaine’s development as a medical treatment http://www.streetinsider.com/Globe+Newswire/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html Tue, 18 Aug 2026 17:23:00 -0400 A.13296698 O.03270327 O.03955888 O.65258044 PBM PSYGD http://www.streetinsider.com/Globe+Newswire/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html <p>NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company focused on the development and supply of nature-derived psychedelic compounds for clinical research and therapeutic applications, today welcomed President Donald J. Trump’s latest announcement supporting the accelerated development of ibogaine as a potential medical treatment in the United States.</p> <p>President Trump announced today that the University of Miami has provided the U.S. Federal Government with its original 1994 ibogaine Investigational New Drug (“IND”) application, which he said could help accelerate ibogaine’s development as a medical treatment http://www.streetinsider.com/Globe+Newswire/Psyence+BioMed+Welcomes+U.S.+Administration%E2%80%99s+Latest+Action+to+Accelerate+Ibogaine+Development/26945518.html Tue, 18 Aug 2026 17:23:00 -0400 A.13296698 O.03270327 O.03955888 O.65258044 PBM PSYGD http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++PSYENCE+BIOMEDICAL+LTD.+++For%3A+Aug+06/26883333.html si-local-file:///var/storage/secattach/20260806/26883333.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++PSYENCE+BIOMEDICAL+LTD.+++For%3A+Aug+06/26883333.html Thu, 06 Aug 2026 16:02:00 -0400 O.03270327 O.65258044 PBM PSYGD http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++PSYENCE+BIOMEDICAL+LTD.+++For%3A+Aug+06/26883333.html si-local-file:///var/storage/secattach/20260806/26883333.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++PSYENCE+BIOMEDICAL+LTD.+++For%3A+Aug+06/26883333.html Thu, 06 Aug 2026 16:02:00 -0400 O.03270327 O.65258044 PBM PSYGD http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++PSYENCE+BIOMEDICAL+LTD.+++For%3A+Aug+06/26883333.html si-local-file:///var/storage/secattach/20260806/26883333.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++PSYENCE+BIOMEDICAL+LTD.+++For%3A+Aug+06/26883333.html Thu, 06 Aug 2026 16:02:00 -0400 O.03270327 O.65258044 PBM PSYGD